Lexaria Bioscience (LEXX) Net Margin (QoQ) (2018 - 2025)
Lexaria Bioscience (LEXX) Net Margin (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Lexaria Bioscience | 10.31 Mn | 6.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2025 | -63,218.00 |
| May 31, 2025 | 63,218.00 |
| Feb 28, 2025 | 8,372.00 |
| Nov 30, 2024 | -115,104.00 |
| Aug 31, 2024 | 47,619.00 |
| May 31, 2024 | 172,906.00 |
| Feb 29, 2024 | -37,945.00 |
| Nov 30, 2023 | -311,034.00 |
| Aug 31, 2023 | 81,506.00 |
| May 31, 2023 | -340,336.00 |
| Feb 28, 2023 | 828,852.00 |
| Nov 30, 2022 | -47,638.00 |
| Aug 31, 2022 | 106,943.00 |
| May 31, 2022 | -704,149.00 |
| Feb 28, 2022 | 1.90 Mn |
| Nov 30, 2021 | -1.06 Mn |
| Aug 31, 2021 | -254,463.00 |
| May 31, 2021 | -104,262.00 |
| Feb 28, 2021 | 2,495.00 |
| Nov 30, 2020 | 88,190.00 |